Laurus Labs' profit grows 32 pc in Dec quarter
Laurus Labs on Monday posted a 32 per cent growth year-on-year to Rs 203 crore. The pharmaceutical firm revenue went up 50 per cent y-o-y to Rs 1,545 crore wh
Stay updated with breaking news from Laurus Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Laurus Labs on Monday posted a 32 per cent growth year-on-year to Rs 203 crore. The pharmaceutical firm revenue went up 50 per cent y-o-y to Rs 1,545 crore wh
Laurus Labs on Monday posted a 32 per cent growth year-on-year to Rs 203 crore
The scrip fell 5.69 per cent to a low of Rs 452.45 on BSE. With this, the scrip has fallen 14.39 per cent in three trading sessions.
The scrip fell 7.34 per cent to close the day at Rs 487.45 on BSE, taking its year-to-date fall to 9.79 per cent.
Laurus Labs’ (Laurus) Q1FY22-23 results instilled confidence in investors regarding its target of achieving US$1bn (billion) in sales in FY22-23